| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 01/30/2003 | WO2003007686A2 Use of copper chelators to inhibit the inactivation of protein c |
| 01/30/2003 | WO2002048180A3 Peptides and/or proteins and use thereof for the production of a therapeutic and/or prophylactic medicament |
| 01/30/2003 | WO2002045523A3 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
| 01/30/2003 | US20030023104 For prolonging or altering the activity of a compound which is a member of the chlorambucil family |
| 01/30/2003 | CA2454418A1 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 01/30/2003 | CA2453987A1 Dolastatin 10 derivatives |
| 01/30/2003 | CA2452322A1 Inhibitors of the ice/ced-3 family of cysteine proteases |
| 01/29/2003 | EP1279665A2 A process for the preparation of perindopril, its analogous compounds and salts thereof using 2,5-dioxo-oxazolidine intermediate compounds |
| 01/29/2003 | EP0910573B1 New amino acid derivatives and their use as thrombin inhibitors |
| 01/29/2003 | CN1394199A Peptide derivatives and their pharmaceutically acceptable salts, processes for preparation of both, and use thereof |
| 01/28/2003 | US6512111 A method for preparing compounds of formula (I) ) wherein cyclization is carried out in a basic medium and in the presence of a phosphonic acid derivative and the use of said method as an intermediate step for preparing a compound |
| 01/28/2003 | US6512092 Solid phase peptide synthesis; in situ generation of amino acid chloride by deblocking; coupling sterically hindered amino acid residues |
| 01/28/2003 | US6512001 D-proline derivatives |
| 01/28/2003 | US6511663 Tri- and tetra-valent monospecific antigen-binding proteins |
| 01/28/2003 | US6511648 Vitronectin receptor antagonist pharmaceuticals |
| 01/28/2003 | CA2124375C Compounds containing a fused bicyclic ring and processes therefor |
| 01/28/2003 | CA2110556C The elucidation and synthesis of antineoplastic tetrapeptide phenylamides of dolastatin 10 |
| 01/28/2003 | CA2110555C Tumor inhibiting tetrapeptide bearing modified phenethyl amides |
| 01/23/2003 | WO2003006620A2 Linear and cyclic melanocortin receptor-specific peptides |
| 01/23/2003 | WO2003006492A2 Biologically active peptides |
| 01/23/2003 | WO2003006490A1 Bridged bicyclic serine protease inhibitors |
| 01/23/2003 | WO2003006489A2 Prodrugs of excitatory amino acids |
| 01/23/2003 | WO2003006444A2 Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity |
| 01/23/2003 | WO2003006021A1 Alpha-hydroxyamide statine derivatives for the treatment of alzh eimer's disease |
| 01/23/2003 | WO2002026775A3 Compositions and methods for regulating apoptosis |
| 01/23/2003 | US20030018193 Beta-alanine derivatives and their use as receptor anatgonists |
| 01/23/2003 | US20030018163 Acylation, amidation; using amine scavenger |
| 01/23/2003 | US20030017996 Antilipemic agents, anticholesterol agents, cardiovascular disorders |
| 01/23/2003 | US20030017995 Dialysis solutions and methods |
| 01/23/2003 | US20030017993 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 01/23/2003 | US20030017992 Crystalline forms |
| 01/23/2003 | US20030017991 Substrates and assays for beta-secretase activity |
| 01/23/2003 | US20030017990 Antiinflammatory agents, rheumatic diseases, antiarthritic agents, inflammatory bowel disorders |
| 01/23/2003 | US20030017976 Anticancer agents; side effect reduction |
| 01/23/2003 | US20030017964 Administration of agents via the PEPT-2 transporter |
| 01/23/2003 | US20030017520 High-efficiency assay for protein mannosyl transferases |
| 01/23/2003 | US20030017245 Novel aspartame powders |
| 01/23/2003 | CA2707767A1 Biologically active peptides |
| 01/23/2003 | CA2453515A1 Linear and cyclic melanocortin receptor-specific peptides |
| 01/23/2003 | CA2453447A1 Alpha-hydroxyamide statine derivatives for the treatment of alzheimer's disease |
| 01/23/2003 | CA2453169A1 Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity |
| 01/23/2003 | CA2452417A1 Compositions comprising the biologicially active peptide ysl |
| 01/23/2003 | CA2449504A1 Bridged bicyclic serine protease inhibitors |
| 01/22/2003 | EP1277761A2 Process for the preparation of peptides |
| 01/22/2003 | EP1276758A2 A glycopeptide and preparation thereof |
| 01/22/2003 | EP1276746A2 Process for preparing lipid ii and derivatives thereof |
| 01/22/2003 | EP1276718A2 Small technetium-99m and rhenium labeled agents and methods for imaging tumors |
| 01/22/2003 | EP1276491A1 Tamandarin and didemnin analogs and methods of making and using them |
| 01/22/2003 | EP1107980B1 CRYSTALLINE FORMS OF EtO2C-CH2-(R)Cgl-Aze-Pab-OH |
| 01/22/2003 | EP1030835B1 Urea derivatives and their use as integrin inhibitors |
| 01/22/2003 | EP0865339B1 Metalloproteinase inhibitors |
| 01/22/2003 | CN1392157A New anti-embolism medicine using small peptide arginine-glycine-aspartic acid (RGD) as leading compound |
| 01/22/2003 | CN1392156A Synthesizing method for propyl-glutdipeptide |
| 01/22/2003 | CN1099425C 新的肽衍生物 New peptide derivatives |
| 01/21/2003 | US6509446 Recombinant genetic information (DNA or RNA), consisting a Chicken Anemia Virus (CAV)-specific nucleotide sequence, useful for diagonestics, vaccination or protein production |
| 01/21/2003 | US6509330 Angiotensin converting enzyme (ACE); neutral endopeptidase (NEP); containing a dipeptide derived from an amino acid, or a conformationally restricted dipeptide mimic |
| 01/21/2003 | US6509315 Didemnin analogs and fragments and methods of making and using them |
| 01/21/2003 | US6509165 Detecting the ability of proinsulin peptide to preferentially stimulate the T-cells of diabetic subjects by measuring the ability of the T-cells to proliferate or ability of the T-cells to produce cytokines |
| 01/21/2003 | US6509100 Fluorinated hydrogn bond stabilized surface modifying agents, articles made therefrom, methods for making and using the same |
| 01/16/2003 | WO2003004517A2 Peyers's patch and/or m-celle targeting ligands |
| 01/16/2003 | WO2003004516A1 Novel chromogenic substances and use thereof for the determination of carboxypeptidase activities |
| 01/16/2003 | WO2002055185A3 Block copolymers for multifunctional self-assembled systems |
| 01/16/2003 | WO2002031109A3 Intracellular delivery of biological effectors by novel transporter peptide sequences |
| 01/16/2003 | WO2002012196A3 Lactam compounds and their use as inhibitors of serine proteases and method |
| 01/16/2003 | US20030013881 Such as 4-((6-(3,5-difluoro-phenyl)-5-(S)-(3-dipropylcarb-amoyl-benzoyl-amino)-2-(R)-ethyl-4-(S)-hydroxy-hexanoylamino)-methyl)-cyclohexanecarboxylic acid for inhibiting secretase activity and cleavage of amyloid precursor protein |
| 01/16/2003 | US20030013847 Pyruvate derivatives |
| 01/16/2003 | US20030013846 Cytoprotective agents |
| 01/16/2003 | US20030013725 Amino acid derivatives |
| 01/16/2003 | US20030013700 Thrombin inhibitors |
| 01/16/2003 | US20030013677 Anticancer agents |
| 01/16/2003 | US20030013660 Dioxolane analogs for improved inter-cellular delivery |
| 01/16/2003 | US20030013658 Small peptides and methods for treatment of asthma and inflammation |
| 01/16/2003 | US20030013657 Reducing oxidation stresses; central nervous system disorders; antiinflammatory agents |
| 01/16/2003 | US20030013656 Reducing oxidation stresses; central nervous system disorders; antiinflammatory agents |
| 01/16/2003 | US20030012817 Modified amino acids and derivatives can form non-covalent mixtures with active biological agents and in an alternate embodiment can releasably carry active agents. Modified amino acids can also form drug containing microspheres. |
| 01/16/2003 | CA2451741A1 Peyers's patch and/or m-celle targeting ligands |
| 01/16/2003 | CA2450194A1 Novel chromogenic substances and use thereof for the determination of carboxypeptidase activities |
| 01/15/2003 | EP1275657A1 Peptide derivatives and medicinal compositions |
| 01/15/2003 | EP1274724A2 Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising alkyl and aryl alanine p2 moieties |
| 01/15/2003 | EP1274693A1 Method for producing 2,5-diketopiperazines, 2,5-diketopiperazines, dipeptides and the use thereof |
| 01/15/2003 | EP1274682A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 01/15/2003 | EP1274323A1 Stability enhancement of sweeteners using salts containing divalent or trivalent cations |
| 01/15/2003 | EP1015627A4 Method for detecting a target compound using a nucleic acid ligand |
| 01/15/2003 | EP0907643B1 Compounds with growth hormone releasing properties |
| 01/15/2003 | EP0880541B1 Derivatives of antibiotic ge2270 factors |
| 01/15/2003 | CN1391580A Peptides |
| 01/15/2003 | CN1391577A Pharmaceutical compositions comprising metal complexes |
| 01/15/2003 | CN1391553A Novel intermediate for sweetener with high sweetness and process for producing the same |
| 01/15/2003 | CN1098838C Substituted N-(indole-2-carbonyl)-beta-alanimamides and derivatives as antidiabetic agents |
| 01/14/2003 | US6506906 Preparation and use of bifunctional molecules having DNA sequence binding specificity |
| 01/14/2003 | US6506903 By reacting 4-methylthiazole with N-halosuccinimide in solvent in presence of 2,2-azobisisobutyronitrile; halogenation, catalysis |
| 01/14/2003 | US6506786 HIV protease inhibitors based on amino acid derivatives |
| 01/14/2003 | US6506761 Substituted hydrazinyl heteroaromatic inhibitors of thrombin |
| 01/14/2003 | US6506760 Substituted hydrazinyl heteroaromatic inhibitors of thrombin |
| 01/14/2003 | US6506759 Retroviral protease inhibitors |
| 01/14/2003 | US6506754 Compounds as anticoagulants |
| 01/14/2003 | US6506734 20(S) camptothecin glycoconjugates |
| 01/14/2003 | US6506731 Elastin peptide analogs and methods of using same |
| 01/14/2003 | US6506362 Peptides and peptide mimetics attached to labels and/or hydrophilic polymmers; treating hematological disorders, particularly thrombocytopenia resulting from chemotherapy, radiation therapy, or bone marrow transfusions |
| 01/14/2003 | CA2250583C Process for the preparation of n-methyl-d-phenylalanyl-n-¬1-¬3-¬(aminoiminomethyl)amino|propyl|-3,3-difluoro-2-oxohexyl|-l-prolinamide |